2023
Brindani N., Vuong L.M., Acquistapace I.M., La Serra M.A., Ortega J.A., Veronesi M., Bertozzi S.M., Summa M., Girotto S., Bertorelli R., Armirotti A., Ganesan A.K., De Vivo M.
Design, Synthesis, In Vitro and In Vivo Characterization of CDC42 GTPase Interaction Inhibitors for the Treatment of Cancer
Journal of Medicinal Chemistry
2023
Bellina F., Berti F., Bertozzi S. M., Bandiera T., Bertozzi F.
Highly diastereoselective Heck-Matsuda reaction with pyrazolyl diazonium salts
New Journal of Chemistry
Article in Press
Journal
2022
Tuccinardi D., Di Mauro A., Lattanzi G., Rossini G., Monte L., Beato I., Spiezia C., Bravo M., Watanabe M., Soare A., Kyanvash S., Armirotti A., Bertozzi S.M., Gastaldelli A., Pedone C., Khazrai Y.M., Pozzilli P., Manfrini S.
An extra virgin olive oil-enriched chocolate spread positively modulates insulin-resistance markers compared with a palm oil-enriched one in healthy young adults: A double-blind, cross-over, randomised controlled trial
Diabetes/Metabolism Research and Reviews, vol. 38, (no. 2)
2022
Jahid S., Ortega J.A., Vuong L.M., Acquistapace I.M., Hachey S.J., Flesher J.L., La Serra M.A., Brindani N., La Sala G., Manigrasso J., Arencibia J.M., Bertozzi S.M., Summa M., Bertorelli R., Armirotti A., Jin R., Liu Z., Chen C.-F., Edwards R., Hughes C.C.W., De Vivo M., Ganesan A.K.
Erratum: Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer (Cell Reports (2022) 39(1), (S221112472200393X), (10.1016/j.celrep.2022.110641))
Cell Reports, vol. 39, (no. 4)
2022
Colini Baldeschi A., Zattoni M., Vanni S., Nikolic L., Ferracin C., La Sala G., Summa M., Bertorelli R., Bertozzi S.M., Giachin G., Carloni P., Bolognesi M.L., De Vivo M., Legname G.
Innovative Non-PrP-Targeted Drug Strategy Designed to Enhance Prion Clearance
Journal of Medicinal Chemistry, vol. 65, (no. 13), pp. 8998-9010
2022
Jahid S., Ortega J. A., Vuong L. M., Hachey S. J., Flesher J. L., La Serra M. A., Brindani N., La Sala G., Manigrasso J., Arencibia J. M., Bertozzi S. M., Summa M., Bertorelli R., Armirotti A., Chen C., Hughes C. C. W., Edwards R., De Vivo M., Ganesan A. K.
Structure-based Design of CDC42 Effector Interaction Inhibitors For the Treatment of Cancer
Cell Reports, vol. 39, pp. 110641
2021
Borgogno M., Savardi A., Manigrasso J., Turci A., Portioli C., Ottonello G., Bertozzi S.M., Armirotti A., Contestabile A., Cancedda L., De Vivo M.
Design, Synthesis,In VitroandIn VivoCharacterization of Selective NKCC1 Inhibitors for the Treatment of Core Symptoms in down Syndrome
Journal of Medicinal Chemistry, vol. 64, (no. 14), pp. 10203-10229
2021
Di Fruscia P., Carbone A., Bottegoni G., Berti F., Giacomina F., Ponzano S., Pagliuca C., Fiasella A., Pizzirani D., Ortega J.-A., Nuzzi A., Tarozzo G., Mengatto L., Giampà R., Penna I., Russo D., Romeo E., Summa M., Bertorelli R., Armirotti A., Bertozzi S.M., Reggiani A., Bandiera T., Bertozzi F.
Discovery and SAR evolution of pyrazole azabicyclo[3.2.1]octane sulfonamides as a novel class of non-covalent N-Acylethanolamine-hydrolysing Acid Amidase (NAAA) inhibitors for oral administration
Journal Medicinal Chemistry
2021
Capurro V., Tomati V., Sondo E., Renda M., Borrelli A., Pastorino C., Guidone D., Venturini A., Giraudo A., Bertozzi S.M., Musante I., Bertozzi F., Bandiera T., Zara F., Galietta L.J.V., Pedemonte N.
Partial rescue of f508del-cftr stability and trafficking defects by double corrector treatment
International Journal of Molecular Sciences, vol. 22, (no. 10)
2021
Barone M., Rampelli S., Biagi E., Bertozzi S.M., Falchi F., Cavalli A., Armirotti A., Brigidi P., Turroni S., Candela M.
Searching for New Microbiome-Targeted Therapeutics through a Drug Repurposing Approach
Journal of Medicinal Chemistry, vol. 64, (no. 23), pp. 17277-17286
2020
Haaranen M., Scuppa G., Tambalo S., Jarvi V., Bertozzi S.M., Armirotti A., Sommer W.H., Bifone A., Hyytia P.
Anterior insula stimulation suppresses appetitive behavior while inducing forebrain activation in alcohol-preferring rats
Translational Psychiatry, vol. 10, (no. 1)
2020
Caputo S., Di Martino S., Cilibrasi V., Tardia P., Mazzonna M., Russo D., Penna I., Summa M., Mandrup Bertozzi S., Realini N., Margaroli N., Migliore M., Ottonello G., Liu M., Lansbury P., Armirotti A., Bertorelli R., Ray S.S., Skerlj R., Scarpelli R.
Design, Synthesis, and Biological Evaluation of a Series of Oxazolone Carboxamides as a Novel Class of Acid Ceramidase Inhibitors
Journal of Medicinal Chemistry, vol. 63, (no. 24), pp. 15821-15851
2020
Arencibia J.M., Brindani N., Franco-Ulloa S., Nigro M., Kuriappan J.A., Ottonello G., Bertozzi S.M., Summa M., Girotto S., Bertorelli R., Armirotti A., De Vivo M.
Design, Synthesis, Dynamic Docking, Biochemical Characterization, and in Vivo Pharmacokinetics Studies of Novel Topoisomerase II Poisons with Promising Antiproliferative Activity
Journal of Medicinal Chemistry, vol. 63, (no. 7), pp. 3508-3521
2020
Liessi N., Pesce E., Braccia C., Bertozzi S.M., Giraudo A., Bandiera T., Pedemonte N., Armirotti A.
Distinctive lipid signatures of bronchial epithelial cells associated with cystic fibrosis drugs, including Trikafta
JCI insight, vol. 5, (no. 16)
2020
Linciano P., Cullia G., Borsari C., Santucci M., Ferrari S., Witt G., Gul S., Kuzikov M., Ellinger B., Santarem N., Cordeiro da Silva A., Conti P., Bolognesi M.L., Roberti M., Prati F., Bartoccini F., Retini M., Piersanti G., Cavalli A., Goldoni L., Bertozzi S.M., Bertozzi F., Brambilla E., Rizzo V., Piomelli D., Pinto A., Bandiera T., Costi M.P.
Identification of a 2,4-diaminopyrimidine scaffold targeting Trypanosoma brucei pteridine reductase 1 from the LIBRA compound library screening campaign
European Journal of Medicinal Chemistry, vol. 189